Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Asthma-II: Pathophysiology and Classification
Asthma: Pathogenesis and Management
COPD: Management Using Bronchodilators and Corticosteroids
Drugs Used in Lower Respiratory Disorders: Overview
Chronic Obstructive Pulmonary Disease
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Dec 11, 2025

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
Published on: April 16, 2019
Venkata Sita Rama Raju Allam1, Alen Faiz2,3,4, Maggie Lam5
1Graduate School of Health, Faculty of Health, The University of Technology Sydney, Ultimo, NSW, Australia.
Inhibition of the receptor for advanced glycation end products (RAGE) pathway, but not Toll-like receptor 4 (TLR4), may protect against airway neutrophilia and hyperresponsiveness in COPD. RAGE deficiency protected mice, while TLR4 deficiency worsened AHR.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: